Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Abbott Laboratories (NYSE:ABT).

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories “purposely marketed” toddler milks to portray them as the next recommended step in a child’s diet – but the sugary drinks can actually cause health issues like obesity ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

AUSTIN (KXAN) — Texas Democratic leadership criticized Gov. Greg Abbott’s legislative priorities, arguing everyday Texans are struggling after three decades of Republican leadership.

Gov. Greg Abbott issued a ban on the use of Chinese-backed artificial intelligence and social media apps on Texas government-issued devices Friday afternoon. The proclamation orders the Texas ...